CNY 20.1
(-1.33%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.53 Billion CNY | 18.33% |
2022 | 1.26 Billion CNY | 31.52% |
2021 | 961.48 Million CNY | 161.45% |
2020 | 330.32 Million CNY | 33.31% |
2019 | 259.51 Million CNY | 23.6% |
2018 | 209.96 Million CNY | 33.55% |
2017 | 185.02 Million CNY | 56.84% |
2016 | 143.89 Million CNY | 73.81% |
2015 | 51.81 Million CNY | -0.48% |
2014 | 48.83 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 81.58 Million CNY | -73.63% |
2024 Q2 | 309.94 Million CNY | 179.13% |
2024 Q1 | 93.53 Million CNY | -74.22% |
2023 Q4 | 182.43 Million CNY | 4.59% |
2023 Q1 | 127.2 Million CNY | -50.96% |
2023 Q2 | 174.94 Million CNY | 37.53% |
2023 FY | - CNY | 18.33% |
2023 Q3 | 174.43 Million CNY | -0.29% |
2022 FY | - CNY | 31.52% |
2022 Q4 | 259.38 Million CNY | 81.58% |
2022 Q3 | 142.85 Million CNY | 14.89% |
2022 Q2 | 124.34 Million CNY | 133.13% |
2022 Q1 | 53.33 Million CNY | -62.15% |
2021 FY | - CNY | 161.45% |
2021 Q2 | 90.71 Million CNY | 16.62% |
2021 Q4 | 140.89 Million CNY | 39.15% |
2021 Q3 | 101.25 Million CNY | 11.62% |
2021 Q1 | 77.78 Million CNY | -19.36% |
2020 FY | - CNY | 33.31% |
2020 Q1 | 64.65 Million CNY | 10.3% |
2020 Q4 | 96.46 Million CNY | 31.73% |
2020 Q3 | 73.22 Million CNY | 1.76% |
2020 Q2 | 71.95 Million CNY | 11.3% |
2019 FY | - CNY | 23.6% |
2019 Q4 | 58.61 Million CNY | 0.0% |
2018 FY | - CNY | 33.55% |
2017 FY | - CNY | 56.84% |
2017 Q1 | 29.54 Million CNY | 0.0% |
2017 Q2 | 29.54 Million CNY | 0.0% |
2016 FY | - CNY | 73.81% |
2015 FY | - CNY | -0.48% |
2014 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Shanghai No.1 Pharmacy Co., Ltd. | 186.51 Million CNY | -725.131% |
Jointown Pharmaceutical Group Co., Ltd | 5.08 Billion CNY | 69.726% |
LBX Pharmacy Chain Joint Stock Company | 3.06 Billion CNY | 49.862% |
Yifeng Pharmacy Chain Co., Ltd. | 4.04 Billion CNY | 61.987% |